
    
      To compare the efficacy and safety of intravitreal Aflibercept monotherapy with the efficacy
      and safety of combined treatment with Aflibercept associated with standard photodynamic
      therapy (PDT) with Verteporfin in age-related macular degeneration (AMD) patients with
      polypoidal choroidal vasculopathy (PCV) in a proof concept study and to identify genetic
      biomarkers for the diagnosis and treatment response of PCV in Caucasians.
    
  